Akums Drugs and Pharmaceuticals Limited

NSE: AKUMS · Healthcare

Overview

Akums Drugs and Pharmaceuticals Limited Share Price & Analysis

₹695.05▲ +2.73%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹695.05
+2.73%
Open
₹—
High
₹709.5
Low
₹672.15
Close
₹695.05
52W High
₹715
52W Low
₹409
Volume
433K
Lot Size
1
Sector
Healthcare
Market Cap
₹10K Cr
Face Value
₹2
Mid Cap

Price Chart

Fundamentals

P/E
39
Sector P/E
54.4
P/B
2.45
EPS
₹16.68
ROE
8.45%
ROCE
14.9%
D/E Ratio
0.05
Div Yield
0.15%
Book Value
₹211
+

Strengths

  • ✓Attractively valued vs sector (P/E 39x vs industry 54.4x)
  • ✓Virtually debt-free
−

Concerns

  • ✗Trading near 52-week high (₹715)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
₹7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
₹1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
₹2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

AKUMS · as of Jun 2026

Promoters75.26%
FII1.91%▲0.53
DII13.44%▼0.92
Public6.67%▲0.38
Others2.73%
CategoryMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters75.26%75.26%75.26%75.26%75.26%75.26%
FII5.77%4.24%2.27%1.14%1.38%1.91%
DII7.39%8.85%9.28%14.41%14.36%13.44%
Public8.84%8.92%10.46%6.45%6.29%6.67%
Others2.73%2.73%2.73%2.73%2.73%2.73%

Corporate Events

Dividend - Re 1 Per Share/Special Dividend - Rs 2 Per Share

Dividend2 Jul 2026

Latest News

All news →

Akums to hold 22nd Annual General Meeting

*Akums to hold 22nd Annual General Meeting* as per a newspaper publication notice. The AGM is a routine annual event for shareholders. No major corporate announcements were disclosed in the filing. Details on dividends or key resolutions are awaited. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM

NSE Filing19 Jun
Low Impact

Akums shares to see e-voting updates for FY2025-26

*Akums shares to see e-voting updates for FY2025-26*. Akums Drugs and Pharmaceuticals has issued a notice and integrated annual report for FY2025-26 to shareholders without registered email IDs. The move ensures compliance with SEBI’s e-voting and investor communication norms. Physical dispatch may lead to minor administrative costs. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnnualReport

NSE Filing19 Jun
Low Impact

Akums announces 22nd AGM and final dividend details.

*Akums announces 22nd AGM and final dividend details.* The company has released an advertisement informing shareholders about the date and logistics of its 22nd Annual General Meeting. It also confirmed the disbursement of **final and special dividends**, details of which are outlined in the filing. Investors should watch for record and payment dates. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend

NSE Filing16 Jun
Low Impact

Akums to host analyst and investor meet

*Akums to host analyst and investor meet* to discuss business updates and strategy. The company has scheduled an investor/analyst meeting, as per a regulatory filing. Such events often provide clarity on guidance and operational performance. No financial figures or major announcements were disclosed. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Pharma

NSE Filing10 Jun
Low Impact

Akums to host analyst and investor meet

*Akums to host analyst and investor meet.* The company has announced a schedule for its upcoming analyst and institutional investor meet. Details on business strategy and performance may be discussed. Investors await further clarity on growth roadmap. 📊 *STOCKS:* AKUMS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet

NSE Filing9 Jun
Low Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
₹1.2K Cr
▼0.2%
₹1.2K Cr
▲13.9%
₹1.0K Cr
▼0.6%
₹1.0K Cr
▼3.0%
₹1.1K Cr
▲4.6%
₹1.0K Cr
▼2.2%
₹1.0K Cr
▲1.4%
₹1.0K Cr
Op. Profit
₹152 Cr
▲3.4%
₹147 Cr
▲56.4%
₹94 Cr
▼27.1%
₹129 Cr
▲37.2%
₹94 Cr
▼22.3%
₹121 Cr
▲0.0%
₹121 Cr
▼5.5%
₹128 Cr
OPM
13.0%
▲0.0%
13.0%
▲44.4%
9.0%
▼30.8%
13.0%
▲44.4%
9.0%
▼25.0%
12.0%
▲0.0%
12.0%
▼7.7%
13.0%
Net Profit
₹81 Cr
▲19.1%
₹68 Cr
▲58.1%
₹43 Cr
▼33.8%
₹65 Cr
▼56.7%
₹150 Cr
▲127.3%
₹66 Cr
▼1.5%
₹67 Cr
▲9.8%
₹61 Cr
EPS (₹)
5.38
▲27.8%
4.21
▲62.5%
2.59
▼35.7%
4.03
▼57.0%
9.38
▲126.6%
4.14
▲0.0%
4.14
▲1.5%
4.08

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2016Mar 2015
Revenue
₹4.4K Cr
▲5.9%
₹4.1K Cr
▼1.4%
₹4.2K Cr
▲14.3%
₹3.7K Cr
▼0.5%
₹3.7K Cr
▲34.9%
₹2.7K Cr
▲12.8%
₹2.4K Cr
▲46.2%
₹1.7K Cr
▲12.8%
₹1.5K Cr
Expenses
₹3.8K Cr
▲5.0%
₹3.7K Cr
▼9.9%
₹4.1K Cr
▲20.6%
₹3.4K Cr
▼10.6%
₹3.8K Cr
▲51.3%
₹2.5K Cr
▲10.9%
₹2.2K Cr
▲48.6%
₹1.5K Cr
▲12.5%
₹1.3K Cr
Op. Profit
₹522 Cr
▲12.3%
₹465 Cr
▲278.0%
₹123 Cr
▼58.2%
₹294 Cr
▲430.3%
₹-89 Cr
▼137.4%
₹238 Cr
▲36.8%
₹174 Cr
▲20.8%
₹144 Cr
▲16.1%
₹124 Cr
OPM
12.0%
▲9.1%
11.0%
▲266.7%
3.0%
▼62.5%
8.0%
▲500.0%
-2.0%
▼122.2%
9.0%
▲28.6%
7.0%
▼22.2%
9.0%
▲12.5%
8.0%
Other Income
₹108 Cr
▲56.5%
₹69 Cr
▲762.5%
₹8 Cr
▼46.7%
₹15 Cr
▲114.3%
₹7 Cr
▼36.4%
₹11 Cr
▼57.7%
₹26 Cr
▲333.3%
₹6 Cr
▲0.0%
₹6 Cr
Interest
₹94 Cr
▲168.6%
₹35 Cr
▼31.4%
₹51 Cr
▲10.9%
₹46 Cr
▲170.6%
₹17 Cr
▲142.9%
₹7 Cr
▼65.0%
₹20 Cr
▼9.1%
₹22 Cr
▼4.3%
₹23 Cr
Depreciation
₹155 Cr
▲1.3%
₹153 Cr
▲21.4%
₹126 Cr
▲11.5%
₹113 Cr
▲18.9%
₹95 Cr
▲35.7%
₹70 Cr
▲4.5%
₹67 Cr
▲76.3%
₹38 Cr
▲22.6%
₹31 Cr
PBT
₹382 Cr
▲10.7%
₹345 Cr
▲866.7%
₹-45 Cr
▼130.0%
₹150 Cr
▲177.7%
₹-193 Cr
▼212.2%
₹172 Cr
▲50.9%
₹114 Cr
▲28.1%
₹89 Cr
▲15.6%
₹77 Cr
Tax %
33.0%
0.0%
▲100.0%
-102.0%
▼391.4%
35.0%
▲16.7%
30.0%
▲7.1%
28.0%
▼54.8%
62.0%
▲24.0%
50.0%
▼2.0%
51.0%
Net Profit
₹256 Cr
▼25.6%
₹344 Cr
▲34300.0%
₹1 Cr
▼99.0%
₹98 Cr
▲139.0%
₹-251 Cr
▼304.1%
₹123 Cr
▲179.5%
₹44 Cr
▼27.9%
₹61 Cr
▲41.9%
₹43 Cr
EPS (₹)
16.21
▼24.6%
21.49
▲7775.0%
-0.28
▼104.2%
6.63
▲118.8%
-35.3
▼103.7%
943.49
▲181.1%
335.61
▼35.9%
523.23
▲42.7%
366.55
Div Payout
18.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2016Mar 2015
Liabilities
Equity Capital
₹31 Cr
▲0.0%
₹31 Cr
▲6.9%
₹29 Cr
▲0.0%
₹29 Cr
▲107.1%
₹14 Cr
▲1300.0%
₹1 Cr
▲0.0%
₹1 Cr
▲0.0%
₹1 Cr
▲0.0%
₹1 Cr
Reserves
₹3.3K Cr
▲8.9%
₹3.0K Cr
▲342.9%
₹681 Cr
▼1.2%
₹689 Cr
▲13.3%
₹608 Cr
▼31.2%
₹884 Cr
▲22.6%
₹721 Cr
▲14.8%
₹628 Cr
▲27.4%
₹493 Cr
Borrowings
₹157 Cr
▲78.4%
₹88 Cr
▼84.4%
₹565 Cr
▼8.7%
₹619 Cr
▲56.7%
₹395 Cr
▲203.8%
₹130 Cr
▼25.7%
₹175 Cr
▼17.8%
₹213 Cr
▼16.5%
₹255 Cr
Other Liabilities
₹2.0K Cr
▲104.0%
₹960 Cr
▼56.9%
₹2.2K Cr
▲17.0%
₹1.9K Cr
▼6.3%
₹2.0K Cr
▲78.8%
₹1.1K Cr
▼0.3%
₹1.1K Cr
▲258.5%
₹318 Cr
▲8.5%
₹293 Cr
Total Liabilities
₹5.4K Cr
▲32.6%
₹4.1K Cr
▲16.9%
₹3.5K Cr
▲8.1%
₹3.2K Cr
▲6.3%
₹3.0K Cr
▲41.7%
₹2.2K Cr
▲5.6%
₹2.0K Cr
▲75.5%
₹1.2K Cr
▲11.4%
₹1.0K Cr
Assets
Fixed Assets
₹1.5K Cr
▲4.2%
₹1.4K Cr
▲17.3%
₹1.2K Cr
▲8.6%
₹1.1K Cr
▲7.4%
₹1.0K Cr
▲12.9%
₹904 Cr
▲40.2%
₹645 Cr
▲28.7%
₹501 Cr
▲12.8%
₹444 Cr
CWIP
₹177 Cr
▲8.6%
₹163 Cr
▼16.4%
₹195 Cr
▲89.3%
₹103 Cr
▲232.3%
₹31 Cr
▲82.4%
₹17 Cr
▼70.2%
₹57 Cr
▲418.2%
₹11 Cr
₹0 Cr
Investments
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
▼100.0%
₹20 Cr
▲233.3%
₹6 Cr
▼66.7%
₹18 Cr
₹0 Cr
Other Assets
₹3.8K Cr
▲49.7%
₹2.5K Cr
▲19.7%
₹2.1K Cr
▲3.8%
₹2.0K Cr
▲2.2%
₹2.0K Cr
▲64.9%
₹1.2K Cr
▼8.8%
₹1.3K Cr
▲110.3%
₹632 Cr
▲5.7%
₹598 Cr
Total Assets
₹5.4K Cr
▲32.6%
₹4.1K Cr
▲16.9%
₹3.5K Cr
▲8.1%
₹3.2K Cr
▲6.3%
₹3.0K Cr
▲41.7%
₹2.2K Cr
▲5.6%
₹2.0K Cr
▲75.5%
₹1.2K Cr
▲11.4%
₹1.0K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2016Mar 2015
Operating CF
₹1.2K Cr
▲154.0%
₹465 Cr
▼6.6%
₹498 Cr
▲181.4%
₹177 Cr
▲453.1%
₹32 Cr
▼75.6%
₹131 Cr
▲367.9%
₹28 Cr
▼68.5%
₹89 Cr
▲23.6%
₹72 Cr
Investing CF
₹-930 Cr
▼69.7%
₹-548 Cr
▼65.6%
₹-331 Cr
▼8.5%
₹-305 Cr
▼29.8%
₹-235 Cr
▼115.6%
₹-109 Cr
▲42.6%
₹-190 Cr
▼54.5%
₹-123 Cr
▲18.0%
₹-150 Cr
Financing CF
₹34 Cr
▼53.4%
₹73 Cr
▲167.6%
₹-108 Cr
▼186.4%
₹125 Cr
▼47.0%
₹236 Cr
▲359.3%
₹-91 Cr
▼139.1%
₹233 Cr
▲529.7%
₹37 Cr
▼43.9%
₹66 Cr
Net Cash Flow
₹285 Cr
▲2950.0%
₹-10 Cr
▼116.9%
₹59 Cr
▲1575.0%
₹-4 Cr
▼112.1%
₹33 Cr
▲147.1%
₹-70 Cr
▼198.6%
₹71 Cr
▲1675.0%
₹4 Cr
▲136.4%
₹-11 Cr
Free Cash Flow
₹958 Cr
▲376.6%
₹201 Cr
▼5.2%
₹212 Cr
▲292.7%
₹-110 Cr
▲50.9%
₹-224 Cr
▼557.1%
₹49 Cr
▲244.1%
₹-34 Cr
▲0.0%
₹-34 Cr
▲56.4%
₹-78 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2016Mar 2015
Debtor Days
67d
▼1.5%
68d
▼6.8%
73d
▼13.1%
84d
▼4.5%
88d
▲23.9%
71d
▼19.3%
88d
▲54.4%
57d
▼16.2%
68d
Inventory Days
110d
▲7.8%
102d
▲13.3%
90d
▼23.1%
117d
▲4.5%
112d
▲20.4%
93d
▼6.1%
99d
▼13.9%
115d
▲0.9%
114d
Days Payable
87d
▼9.4%
96d
▲26.3%
76d
▼16.5%
91d
▼1.1%
92d
▲24.3%
74d
▼29.5%
105d
▲75.0%
60d
▼10.4%
67d
Cash Conv. Cycle
89d
▲20.3%
74d
▼14.9%
87d
▼21.6%
111d
▲1.8%
109d
▲21.1%
90d
▲9.8%
82d
▼26.8%
112d
▼2.6%
115d
Working Capital Days
66d
▼7.0%
71d
▲77.5%
40d
▼13.0%
46d
▼6.1%
49d
▼25.8%
66d
▲20.0%
55d
▼24.7%
73d
▼6.4%
78d
ROCE
15.0%
▼6.3%
16.0%
▲700.0%
2.0%
▼90.9%
22.0%
▲237.5%
-16.0%
▼180.0%
20.0%
—
14.0%
—

Source: Screener.in · Lower days = better efficiency

About Akums Drugs and Pharmaceuticals Limited

Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services.[1]

Healthcare · Pharmaceuticals & Biotechnology

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is Akums Drugs and Pharmaceuticals Limited share price today?▾
Akums Drugs and Pharmaceuticals Limited (AKUMS) is currently trading at ₹695.05 on NSE, up 2.73% as of the last market session. Prices update daily after market close on MarketNetra.
Is Akums Drugs and Pharmaceuticals Limited available in F&O (Futures & Options)?▾
Yes, Akums Drugs and Pharmaceuticals Limited (AKUMS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Akums Drugs and Pharmaceuticals Limited 52-week high and low?▾
Akums Drugs and Pharmaceuticals Limited's 52-week high is ₹715 and the 52-week low is ₹409. The current price of ₹695.05 is 2.8% below the 52W high.
What is Akums Drugs and Pharmaceuticals Limited P/E ratio?▾
Akums Drugs and Pharmaceuticals Limited's current P/E ratio is 39. This indicates the market is paying ₹39 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Akums Drugs and Pharmaceuticals Limited options?▾
Akums Drugs and Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade AKUMS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.